Skip to main content
. Author manuscript; available in PMC: 2019 May 22.
Published in final edited form as: Cell Rep. 2018 May 22;23(8):2467–2481. doi: 10.1016/j.celrep.2018.04.092

Figure 6. Modulation of MAPK/ERK signaling enhances arterial specification and definitive hematopoiesis from hESCs.

Figure 6.

(A) Experimental scheme. Effect of LY294002 and U0126 on arterial HE specification (B) and (C), hematopoietic (D)-(E), CFC (F) and T cell development (G) and (H) from hESCs. Bars in (C), (E), (F) and (H) are mean ± SD of at least three independent experiments; *p<0.05, **p <0.01; ***p<0.001. See also Figure S5-S6.